Valuation: INVO Fertility, Inc.

Market Cap 2.72M 2.43M 2.24M 2.03M 3.81M 258M 3.87M 27.01M 10.69M 135M 10.21M 9.99M 427M P/E 2026 *
-0.02x
P/E 2027 * -0.07x
Enterprise Value 2.72M 2.43M 2.24M 2.03M 3.81M 258M 3.87M 27.01M 10.69M 135M 10.21M 9.99M 427M EV / Sales 2026 *
0.26x
EV / Sales 2027 * 0.17x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day+7.00%
1 week+2.28%
Current month-37.34%
1 month-44.09%
3 months-44.09%
6 months-73.72%
Current year-84.84%
1 week 0.53
Extreme 0.529
0.64
1 month 0.51
Extreme 0.51
1.04
Current year 0.51
Extreme 0.51
22.9
1 year 0.51
Extreme 0.51
26.58
3 years 0.51
Extreme 0.51
1,785.46
5 years 0.51
Extreme 0.51
1,785.46
10 years 0.51
Extreme 0.51
1,785.46
Date Insider Type Main position Quantity % Market Cap. Importance
30/12/25 Other

Chief Financial Officer

4,399 0.2326%
03/12/25 Sell

Director

7 0.0004%
26/08/25 Other

Director

45,000 4.8477%
Change 5-day change 1-year change 3-year change Capi.($)
+7.00%+2.28%-97.79% - 2.72M
+1.16%-1.13%-17.92%+8.27% 179B
+0.02%+4.24%-19.82%+16.53% 118B
-1.22%+0.70%+1.27%+31.80% 117B
+2.29%+17.36%-41.94%+9.49% 93.26B
-2.21%-2.91%+0.74%+75.30% 63.16B
-1.06%+1.75%+13.50%+80.00% 55.68B
-0.75%+3.73%+6.64%-22.28% 54.18B
-1.13%+0.00%-12.25%+31.02% 44.15B
+0.17%+5.85%-4.92%-10.64% 33.95B
Average +0.43%+3.47%-17.25%+24.39% 75.84B
Weighted average by Cap. -0.00%+3.09%-11.69%+22.47%

Financials

2026 *2027 *
Net sales 10.42M 9.3M 8.6M 7.79M 14.57M 989M 14.81M 103M 40.95M 518M 39.1M 38.27M 1.63B 16.46M 14.7M 13.58M 12.31M 23.02M 1.56B 23.4M 163M 64.7M 819M 61.78M 60.46M 2.58B
Net income -5.44M -4.86M -4.49M -4.07M -7.61M -517M -7.74M -54.03M -21.39M -271M -20.43M -19.99M -853M -3.03M -2.7M -2.5M -2.26M -4.23M -287M -4.3M -30.04M -11.89M -151M -11.36M -11.11M -474M
Net Debt - -
Projected Income Statement - Annual - INVO Fertility, Inc.
Logo INVO Fertility, Inc.
INVO Fertility Inc. is a healthcare services fertility company, which is engaged in expanding access to assisted reproductive technology (ART) care to patients in need. The Company’s principal commercial strategy is focused on building, acquiring, and operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, profitable in vitro fertilization (IVF) clinics. The Company has four operational fertility clinics in the United States. The Company is also engaged in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more connected, intimate, and affordable experience in comparison to other ART treatments.
Employees
-
Date Price Change Volume
23/10/26 $0.5703 +7.00% 86,699
22/10/26 $0.5330 -2.67% 59,588
21/10/26 $0.5476 -8.98% 76,391
20/10/26 $0.6016 +0.10% 69,378
19/10/26 $0.6010 +7.78% 94,468
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.5703USD
Average target price
20.00USD
Spread / Average Target
+3,406.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - INVO Fertility, Inc.